Brinavess approved in Europe

The EC, Iceland and Norway approved Brinavess IV vernakalant from Merck & Co. Inc. (NYSE:MRK) for converting recent onset atrial fibrillation (AF) to sinus rhythm in adults. Merck, which has rights to...